Update in GVHD Prophylaxis: Novel Pharmacologic and Graft Manipulation Strategies
- 24 March 2025
- journal article
- review article
- Published by Wiley in American Journal of Hematology
- Vol. 100 (S3) , 30-39
Abstract
Prevention of graft‐versus‐host disease (GVHD) is critical to successful allogeneic hematopoietic cell transplantation (HCT), but for many years was difficult to achieve. Advances in the understanding of allogeneic HCT biology and immunology have paved the way for novel clinical approaches to GVHD prophylaxis, highlighted by the broad adoption of posttransplant cyclophosphamide and the approval of abatacept by the US Food and Drug Administration to prevent acute GVHD. Patients undergoing allogeneic HCT are now experiencing severe acute GVHD at historically low rates, and significant improvements in preventing chronic GVHD are also being achieved. This review highlights key pharmacological approaches and graft manipulation strategies being used or investigated for GVHD prophylaxis. Furthermore, we discuss the ongoing unmet needs in GVHD prevention and the challenges in addressing these areas in future clinical trials.Keywords
This publication has 71 references indexed in Scilit:
- HLA Typing by Next-Generation SequencingClinics In Laboratory Medicine, 2022
- Peritransplantation Use of Ruxolitinib in MyelofibrosisTransplantation and Cellular Therapy, 2020
- Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research StudyTransplantation and Cellular Therapy, 2020
- B cells in chronic graft-versus-host diseaseHuman Immunology, 2019
- Increased Foxp3+Helios+ Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T CellsTransplantation and Cellular Therapy, 2017
- Response of Steroid-Refractory Acute GVHD to α1-AntitrypsinTransplantation and Cellular Therapy, 2016
- In Vivo T Cell Costimulation Blockade with Abatacept for Acute Graft-versus-Host Disease Prevention: A First-in-Disease TrialTransplantation and Cellular Therapy, 2013
- Characteristics of CliniMACS® System CD34-Enriched T Cell-Depleted Grafts in a Multicenter Trial for Acute Myeloid Leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0303Transplantation and Cellular Therapy, 2012
- Expression of CD62L on Donor CD4+ T Cells in Allografts: Correlation with Graft-Versus-Host Disease after Unmanipulated Allogeneic Blood and Marrow TransplantationJournal of Clinical Immunology, 2009
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideTransplantation and Cellular Therapy, 2008